MetLife Investment Management LLC Sells 15,127 Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO)
MetLife Investment Management LLC decreased its position in shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 28.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,020 shares of the company’s stock after selling 15,127 shares during the period. MetLife Investment […]
MetLife Investment Management LLC decreased its position in shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 28.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,020 shares of the company’s stock after selling 15,127 shares during the period. MetLife Investment […]
-logo-1200x675.png?v=20240604144205&w=240&h=240&zc=2){kind=logo}
